GSDMD and central nervous system cancer: The survival of glioma patients with high GSDMA expression was poor (Figure 2(c); p = 0.0042); similarly, survival time was low in patients with high expression of GSDMD (Figure 2(f); p < 0.0001) and GSDME (Figure 2(g); p = 0.00027).